These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9489875)

  • 1. Elevated plasma thymosin-alpha1 levels in lung cancer patients.
    Sasaki H; Fujii Y; Masaoka A; Yamakawa Y; Fukai I; Kiriyama M; Saito Y; Matsui H
    Eur J Cardiothorac Surg; 1997 Dec; 12(6):885-91. PubMed ID: 9489875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
    Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
    Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of plasma thymosin alpha1 measurements in gastric cancer patients.
    Mitani M; Kuwabara Y; Kawamura H; Sato A; Hattori K; Fujii Y
    World J Surg; 2000 Apr; 24(4):455-8. PubMed ID: 10706919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elastase levels in small and non-small cell lung carcinoma.
    Güner G; Kirkali G; Baskin Y; Karlikaya C; Akkoçlu A
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):305S. PubMed ID: 8224451
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM28 is a serological and histochemical marker for non-small-cell lung cancers.
    Kuroda H; Mochizuki S; Shimoda M; Chijiiwa M; Kamiya K; Izumi Y; Watanabe M; Horinouchi H; Kawamura M; Kobayashi K; Okada Y
    Int J Cancer; 2010 Oct; 127(8):1844-56. PubMed ID: 20112342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suitability of limited resection in lung cancer].
    Nakamura H; Hiyoshi T; Katsuumi T; Hirakuri S; Taguchi M; Ikeda T; Hirano T; Sakai H; Saito M; Konaka C; Kato H
    Jpn J Thorac Cardiovasc Surg; 1998 Apr; 46 Suppl():119-20. PubMed ID: 9642811
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.
    Miyazaki K; Kurishima K; Kagohashi K; Kawaguchi M; Ishikawa H; Satoh H; Hizawa N
    J Clin Lab Anal; 2010; 24(5):295-9. PubMed ID: 20872562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and postoperative sequential study on the serum gastrin level in patients with lung cancer.
    Zhou Q; Zhang H; Pang X; Yang J; Tain Z; Wu Z; Yang Z
    J Surg Oncol; 1992 Sep; 51(1):22-5. PubMed ID: 1325575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study on the diagnosis and prognosis of lung cancer by using new simultaneously observed seromarkers.
    Zhang Q; Ren H; Wang B
    Ann N Y Acad Sci; 1995 Sep; 768():337-40. PubMed ID: 8526382
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
    Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
    Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer in middle-aged patients.
    Kurishima K; Satoh H; Ishikawa H; Yamashita YT; Kamma H; Ohtsuka M; Sekizawa K
    Oncol Rep; 2001; 8(4):851-3. PubMed ID: 11410797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Leśniewska K; Wiktorowicz K
    Pneumonol Alergol Pol; 2008; 76(5):321-6. PubMed ID: 19003761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.
    Vlachostergios PJ; Oikonomou KG; Gibilaro E; Apergis G
    Cancer Biomark; 2015; 15(6):725-34. PubMed ID: 26406401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural cell adhesion molecule and prognosis of surgically resected lung cancer.
    Pujol JL; Simony J; Demoly P; Charpentier R; Laurent JC; Daurès JP; Lehmann M; Guyot V; Godard P; Michel FB
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1071-5. PubMed ID: 8214927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers and IL-2R in lung cancer.
    Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL
    Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of serum Bcl-2 levels in advanced lung cancer patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
    Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamic study on plasma antidiuretic hormone before and after surgery for lung cancers].
    Yang J
    Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):360-1. PubMed ID: 1337892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.